It has been reported that the levels of Ang-1 and Ang-2 have been elevated in preoperative serum samples of women with ovarian cancers as compared to the samples of healthy women or women with benign or borderline ovarian neoplasms [11]. This evidence concerns the gene ANGPT1 and ovarian cancer.